I’ve got a long list of goals before the year ends, but the one haunting me at 2 AM is “Hands-On ML." No more half read chapters, unfinished notebooks.

#39 - ch 03 exercises done, reading ch 04 (HOML) - revised linear regression (pretty basic) but what i didn't know earlier was computational complexity - read about Moore-Penrose matrix inverse - biochem engg: read a few pages on mathematical models of microbial growth

fuck it, i'm installing tonight

do it for the love of the game

Been looping this since last night, easily my album of the year.

#38 - HOML Ch. 03 done - worked on MNIST dataset, trained binary and multi-class classifiers - tomorrow, we finish exercise questions

Been cooking the new @OpenBioAI update for a while. Check it out. Made with love. https://t.co/uSn9ZVJava

Go try out Workspace @OpenBioAI

I guess people don't understand, blocking doesn't work here lol

now that my sem is over, it's time to grind and poast. i'll try to be consistent with my ml and math revision, no guarantees cuz biochemical engg is literally a toxic ex (yes, i do want her back)

The Manga guide to Linear Algebra is such a fun read lol

if you are smart, don’t be rude. in the long run, nobody will care about your intelligence if you are not easy to work with.

Tame Impala's new album absolutely slaps

crazy that gemini dot com doesn't redirect to Google Gemini

There's a Rabbi Shergill song for every situation in your life

I'll rather spread science than slop

I hate writing a good thread here, absolutely 0 reach if you're spreading science

If you're learning Linux CLI like me and keep forgetting which command does what, just type tldr <command> > works offline > available for all the major distros > gives short, practical examples (no man-page overload)

This specific mechanism actually seems novel, but for those unfamiliar with immunology literature: - Silmitasertib has already been shown to modulate MHC (specifically HLA-I) on tumors [1] - CK2 known to sit on the IFN > STAT1>IRF1>MHC axis [2] - CK2 inhibition known to

The novel hypothesis? Virtual drug screening of 4,000 drugs to find a drug that boosts antigen presentation (MHC-I) but only under low interferon (IFN). It flagged Silmitasertib, a kinase inhibitor. Predicted it boosts MHC-I only when IFN is low. Wet labs proved it was correct